Clinical Research
Nashville Neuroscience Group, P.C. has been active in pharmaceutical clinical trials for many years. These clinical trials aid in the research of new treatments for migraine and other neurological disorders.
To determine if you are eligible to participate, please fill out the form below or contact Nichole Sims or Jon Martin by calling 615-284-4680 ext. 4523.
Studies currently accepting enrollment:
Adolescent Migraine Study- TEENZ (Trial of Evaluation and Efficacy of Nasal spray for ZOMIG)Currently enrolling patients in a clinical trial to evaluate the effectiveness of a nasal spray used to treat adolescents with moderate to severe migraine headaches. Between ages 12-17 Male or female who have at least 2 Migraines a month.
Post-traumatic headache Study (Evaluation of the Efficacy of Treximet for Prevention of Post Traumatic Headache Associated with Cognitive Dysfunction)
Currently enrolling patients in a clinical trial to evaluate the efficacy of Treximet in the reduction of number of days of post traumatic headache and associated symptoms over a 30-day treatment period. To evaluate improvement in cognitive efficiency.
Botox Study (An open-label, multicenter study of the long-term efficacy, safety and tolerability of BOTOX (onabotulinumtoxinA) for the porphylaxis of headaches in adult patients with chronic migraine)
Currently enrolling patients in a clinical trial to evaluate the long-term efficacy, safety and tolerability of BOTOX (onabotulinumtoxinA) for the porphylaxis of headaches in adult patients with chronic migraine.
Upcoming Trials
- Evaluation of hemodynamic outcomes with BREVIBLOC PREMIXED INJECTION (Esmolol Hydrochloride) in patients with Supraventricular Tachycardia/Atrial Fibrillation.
